Form 4 for NRC NRC HEALTH
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001008886-24-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-01-04 | 2024-01-02+ | NRC | Amandla MK Trust | 10% | S - Sale | $40.86 | -321.2K | 3.84M | -8% | -$13.12M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 20,600 | $41.18 | 3,958,715 | I By Amandla LLC | — | — | (F2) The price in Column 4 is a weighted average price. The prices actually ranged from $41.00 to $41.335, inclusive. |
| 2 | Common | Common Stock | 2024-01-02 | S | D | 180,500 | $40.21 | 3,979,315 | I By Amandla LLC | — | — | (F1) The price in Column 4 is a weighted average price. The prices actually ranged from $40.00 to $40.995, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), and (3) of this Form 4. |
| 3 | Common | Common Stock | 2024-01-03 | S | D | 120,139 | $41.77 | 3,838,576 | I By Amandla LLC | — | — | (F3) The price in Column 4 is a weighted average price. The prices actually ranged from $41.535 to $42.11, inclusive. |